This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vasudevan, K. M.
Right arrow Articles by Rangnekar, V. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vasudevan, K. M.
Right arrow Articles by Rangnekar, V. M.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, February 2004, p. 1007-1021, Vol. 24, No. 3
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.3.1007-1021.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Suppression of PTEN Expression by NF-{kappa}B Prevents Apoptosis

Krishna Murthi Vasudevan,1 Sushma Gurumurthy,2 and Vivek M. Rangnekar1,2,3,4*

Departments of Microbiology, Immunology, and Molecular Genetics,1 Radiation Medicine,3 Graduate Center for Toxicology,2 Markey Cancer Center, University of Kentucky, Lexington, Kentucky 405364

Received 4 April 2003/ Returned for modification 27 May 2003/ Accepted 27 October 2003

NF-{kappa}B is a heterodimeric transcription activator consisting of the DNA binding subunit p50 and the transactivation subunit p65/RelA. NF-{kappa}B prevents cell death caused by tumor necrosis factor (TNF) and other genotoxic insults by directly inducing antiapoptotic target genes. We report here that the tumor suppressor PTEN, which functions as a negative regulator of phosphatidylinositol (PI)-3 kinase/Akt-mediated cell survival pathway, is down regulated by p65 but not by p50. Moreover, a subset of human lung or thyroid cancer cells expressing high levels of endogenous p65 showed decreased expression of PTEN that could be rescued by specific inhibition of the NF-{kappa}B pathway with I{kappa}B overexpression as well as with small interfering RNA directed against p65. Importantly, TNF, a potent inducer of NF-{kappa}B activity, suppressed PTEN gene expression in IKKß+/+ cells but not in IKKß-/- cells, which are deficient in the NF-{kappa}B activation pathway. These findings indicated that NF-{kappa}B activation was necessary and sufficient for inhibition of PTEN expression. The promoter, RNA, and protein levels of PTEN are down-regulated by NF-{kappa}B. The mechanism underlying suppression of PTEN expression by NF-{kappa}B was independent of p65 DNA binding or transcription function and involved sequestration of limiting pools of transcriptional coactivators CBP/p300 by p65. Restoration of PTEN expression inhibited NF-{kappa}B transcriptional activity and augmented TNF-induced apoptosis, indicating a negative regulatory loop involving PTEN and NF-{kappa}B. PTEN is, thus, a novel target whose suppression is critical for antiapoptosis by NF-{kappa}B.


* Corresponding author. Mailing address: Department of Radiation Medicine, University of Kentucky, Combs Research Building, Rm. 303, 800 Rose St., Lexington, KY 40536. Phone: (859) 257-2677. Fax: (859) 257-9608. E-mail: vmrang01{at}pop.uky.edu.


Molecular and Cellular Biology, February 2004, p. 1007-1021, Vol. 24, No. 3
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.3.1007-1021.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Park, S., Zhao, D., Hatanpaa, K. J., Mickey, B. E., Saha, D., Boothman, D. A., Story, M. D., Wong, E. T., Burma, S., Georgescu, M.-M., Rangnekar, V. M., Chauncey, S. S., Habib, A. A. (2009). RIP1 Activates PI3K-Akt via a Dual Mechanism Involving NF-{kappa}B-Mediated Inhibition of the mTOR-S6K-IRS1 Negative Feedback Loop and Down-regulation of PTEN. Cancer Res. 69: 4107-4111 [Abstract] [Full Text]  
  • Fukuda, R.-i., Tsuchiya, K., Suzuki, K., Itoh, K., Fujita, J., Utsunomiya, A., Tsuji, T. (2009). Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-{kappa}B Pathway. J. Biol. Chem. 284: 2680-2689 [Abstract] [Full Text]  
  • Kasinski, A. L., Du, Y., Thomas, S. L., Zhao, J., Sun, S.-Y., Khuri, F. R., Wang, C.-Y., Shoji, M., Sun, A., Snyder, J. P., Liotta, D., Fu, H. (2008). Inhibition of I{kappa}B Kinase-Nuclear Factor-{kappa}B Signaling Pathway by 3,5-Bis(2-flurobenzylidene)piperidin-4-one (EF24), a Novel Monoketone Analog of Curcumin. Mol. Pharmacol. 74: 654-661 [Abstract] [Full Text]  
  • Schwab, M., Reynders, V., Loitsch, S., Shastri, Y. M., Steinhilber, D., Schroder, O., Stein, J. (2008). PPAR{gamma} is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells. Carcinogenesis 29: 1407-1414 [Abstract] [Full Text]  
  • Han, S., Ritzenthaler, J. D., Zheng, Y., Roman, J. (2008). PPAR{beta}/{delta} agonist stimulates human lung carcinoma cell growth through inhibition of PTEN expression: the involvement of PI3K and NF-{kappa}B signals. Am. J. Physiol. Lung Cell. Mol. Physiol. 294: L1238-L1249 [Abstract] [Full Text]  
  • Choi, H.-J., Chung, T.-W., Kim, S.-J., Cho, S.-Y., Lee, Y.-S., Lee, Y.-C., Ko, J.-H., Kim, C.-H. (2008). The AP-2{alpha} transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene. Glycobiology 18: 395-407 [Abstract] [Full Text]  
  • Teresi, R. E., Planchon, S. M., Waite, K. A., Eng, C. (2008). Regulation of the PTEN promoter by statins and SREBP. Hum Mol Genet 17: 919-928 [Abstract] [Full Text]  
  • Rottmann, S., Speckgens, S., Luscher-Firzlaff, J., Luscher, B. (2008). Inhibition of apoptosis by MAD1 is mediated by repression of the PTEN tumor suppressor gene. FASEB J. 22: 1124-1134 [Abstract] [Full Text]  
  • Vasudevan, K. M., Burikhanov, R., Goswami, A., Rangnekar, V. M. (2007). Suppression of PTEN Expression Is Essential for Antiapoptosis and Cellular Transformation by Oncogenic Ras. Cancer Res. 67: 10343-10350 [Abstract] [Full Text]  
  • Wang, Q., Zhou, Y., Wang, X., Chung, D. H., Evers, B. M. (2007). Regulation of PTEN Expression in Intestinal Epithelial Cells by c-Jun NH2-Terminal Kinase Activation and Nuclear Factor-{kappa}B Inhibition. Cancer Res. 67: 7773-7781 [Abstract] [Full Text]  
  • Haussmann, H.-J. (2007). Smoking and Lung Cancer: Future Research Directions. International Journal of Toxicology 26: 353-364 [Abstract] [Full Text]  
  • Pezzolesi, M. G., Zbuk, K. M., Waite, K. A., Eng, C. (2007). Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. Hum Mol Genet 16: 1058-1071 [Abstract] [Full Text]  
  • Xia, D., Srinivas, H., Ahn, Y.-h., Sethi, G., Sheng, X., Yung, W. K. A., Xia, Q., Chiao, P. J., Kim, H., Brown, P. H., Wistuba, I. I., Aggarwal, B. B., Kurie, J. M. (2007). Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF{kappa}B-dependent Pathway. J. Biol. Chem. 282: 3507-3519 [Abstract] [Full Text]  
  • Gururajan, M., Dasu, T., Shahidain, S., Jennings, C. D., Robertson, D. A., Rangnekar, V. M., Bondada, S. (2007). Spleen Tyrosine Kinase (Syk), a Novel Target of Curcumin, Is Required for B Lymphoma Growth. J. Immunol. 178: 111-121 [Abstract] [Full Text]  
  • Goormachtigh, G., Ouk, T.-S., Mougel, A., Tranchand-Bunel, D., Masy, E., Le Clorennec, C., Feuillard, J., Bornkamm, G. W., Auriault, C., Manet, E., Fafeur, V., Adriaenssens, E., Coll, J. (2006). Autoactivation of the Epstein-Barr Virus Oncogenic Protein LMP1 during Type II Latency through Opposite Roles of the NF-{kappa}B and JNK Signaling Pathways.. J. Virol. 80: 7382-7393 [Abstract] [Full Text]  
  • Huber, L. C., Distler, O., Tarner, I., Gay, R. E., Gay, S., Pap, T. (2006). Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford) 45: 669-675 [Abstract] [Full Text]  
  • Liu, S. F., Malik, A. B. (2006). NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 290: L622-L645 [Abstract] [Full Text]  
  • Flaherty, D. M., Monick, M. M., Hinde, S. L. (2006). Human Alveolar Macrophages Are Deficient in PTEN: THE ROLE OF ENDOGENOUS OXIDANTS. J. Biol. Chem. 281: 5058-5064 [Abstract] [Full Text]  
  • Han, S., Roman, J. (2006). Rosiglitazone suppresses human lung carcinoma cell growth through PPAR{gamma}-dependent and PPAR{gamma}-independent signal pathways.. Molecular Cancer Therapeutics 5: 430-437 [Abstract] [Full Text]  
  • White, E. S., Atrasz, R. G., Hu, B., Phan, S. H., Stambolic, V., Mak, T. W., Hogaboam, C. M., Flaherty, K. R., Martinez, F. J., Kontos, C. D., Toews, G. B. (2006). Negative Regulation of Myofibroblast Differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10). Am. J. Respir. Crit. Care Med. 173: 112-121 [Abstract] [Full Text]  
  • Dave, B., Eason, R. R., Till, S.R., Geng, Y., Velarde, M. C., Badger, T. M., Simmen, R. C.M. (2005). The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. Carcinogenesis 26: 1793-1803 [Abstract] [Full Text]  
  • Imamura, T., Imamura, C., Iwamoto, Y., Sandell, L. J. (2005). Transcriptional Co-activators CREB-binding Protein/p300 Increase Chondrocyte Cd-rap Gene Expression by Multiple Mechanisms Including Sequestration of the Repressor CCAAT/Enhancer-binding Protein. J. Biol. Chem. 280: 16625-16634 [Abstract] [Full Text]  
  • Levinthal, D. J., DeFranco, D. B. (2005). Reversible Oxidation of ERK-directed Protein Phosphatases Drives Oxidative Toxicity in Neurons. J. Biol. Chem. 280: 5875-5883 [Abstract] [Full Text]  
  • Tell, G., Pines, A., Arturi, F., Cesaratto, L., Adamson, E., Puppin, C., Presta, I., Russo, D., Filetti, S., Damante, G. (2004). Control of Phosphatase and Tensin Homolog (PTEN) Gene Expression in Normal and Neoplastic Thyroid Cells. Endocrinology 145: 4660-4666 [Abstract] [Full Text]